Author Correction: The Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signalling (Nature Cell Biology, (2014), 17, 1, (81-94), 10.1038/ncb3082) Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Molecular Targeted Therapy
  • Neoplasms

abstract

  • © 2019, The Author(s), under exclusive licence to Springer Nature Limited. In the version of this Article originally published the same blot was inadvertently presented as both p-Rb and Cyclin A in Fig. 2a. This blot corresponds to the p-Rb panel, as can be seen in the unprocessed version of these blots in Supplementary Fig. 9. The corrected version of the panel is shown below, together with a completely uncropped image of both blots. In addition, in the ‘Viral transduction’ section of the Methods, the pLKO.1 plasmids encoding short hairpin RNAs targeting human Rnd1 were incorrectly listed as clones TRCN0000018338 and TRCN0000039977. The correct clone numbers are TRCN0000047434 and TRCN0000047435. (Figure presented.).

publication date

  • January 2019

Research

keywords

  • Article

Identity

Digital Object Identifier (DOI)

  • 10.1038/s41556-019-0288-3